Life
Maryland Legislation Seeks Pharma Transparency in Disease Awareness Initiatives
A proposed bill in Maryland mandates that pharmaceutical companies and patient organizations disclose their affiliations with disease awareness campaigns, aiming to improve transparency.
Editorial Staff
1 min read
On March 18, 2026, a new bill was introduced in the Maryland legislature focused on enhancing transparency within the pharmaceutical sector.
The legislation requires drug manufacturers and patient advocacy groups to reveal their connections to disease awareness initiatives.
This move is intended to bolster trust in these campaigns and ensure that stakeholders are aware of potential conflicts of interest.